Serotypes and genotypes of Streptococcus pneumoniae causing pneumonia and acute exacerbations in patients with chronic obstructive pulmonary disease

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 3, 2011, Pages 487-493

  Domenech, Arnau ^a,b   Ardanuy, Carmen ^a,b   Calatayud, Laura ^a,b   Santos, Salud ^a   Tubau, Fe ^a,b   Grau, Immaculada ^a,b   Verdaguer, Ricard ^a,b   Dorca, Jordi ^a,b   Pallares, Román ^a,b   Martin, Rogelio ^a   Liñares, Josefina ^a,b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

COPD; S. pneumoniae; Streptococcus pseudopneumoniae

Indexed keywords

CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN G; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLOMBIA; CONTROLLED STUDY; DENMARK; DISEASE EXACERBATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NETHERLANDS; NONHUMAN; PNEUMONIA; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIAE; SWEDEN; UNITED STATES;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING; MULTILOCUS SEQUENCE TYPING; PHENOTYPE; PNEUMONIA, PNEUMOCOCCAL; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 79951528457     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq480     Document Type: Article

References (30)

1. Buist AS, McBurnie MA, Vollmer WM et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-50.
2. Miravitlles M, Soriano JB, Garcia-Rio F et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 2009; 64: 863-8.
3. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 2355-65.
4. Soler-Cataluña JJ, Martinez-Garcia MA, Roman SP et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-31.
5. Garcia-Vidal C, Carratala J, Fernandez-Sabe N et al. Aetiology of, and risk factors for, recurrent community-acquired pneumonia. Clin Microbiol Infect 2009; 15: 1033-8.
6. Fenoll A, Granizo JJ, Aguilar L et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol 2009; 47: 1012-20.
7. Liñares J, Ardanuy C, Pallares R et al. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect 2010; 16: 402-10.
8. Pallares R, Liñares J, Vadillo M et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995; 333: 474-80.
9. Calix JJ, Nahm MH. A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene. J Infect Dis 2010; 202: 29-38.
10. Roson B, Carratala J, Verdaguer R et al. Prospective study of the usefulness of sputum Gram stain in the initial approach to community-acquired pneumonia requiring hospitalization. Clin Infect Dis 2000; 31: 869-74.
11. Pauwels RA, Buist AS, Calverley PM et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-76.
12. Charlson M, Szatrowski TP, Peterson J et al. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47: 1245-51.
13. Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement M100-S18. CLSI, Wayne, PA, USA, 2008.
14. CDC. PCR Deduction of Pneumococcal Serotypes. http://www.cdc.gov/ncidod/biotech/strep/pcr.htm (5 April 2010, date last accessed).
15. McGee L, McDougal L, Zhou J et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the Pneumococcal Molecular Epidemiology Network. J Clin Microbiol 2001; 39: 2565-71.
16. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-9.
17. Enright MC, Spratt BG. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 1998; 144: 3049-60.
18. Multi Locus Sequence Typing (MLST). http://spneumoniae.mlst.net (4 June 2010, date last accessed).
19. Chen DK, McGeer A, de Azavedo JC et al. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network. N Engl J Med 1999; 341: 233-9.
20. Calbo E, Valdés E, Ochoa de Echagüen A et al. Bacteraemic pneumococcal pneumonia in COPD patients: better outcomes than expected. Eur J Clin Microbiol Infect Dis 2009; 28: 971-6.
21. Liñares J, Pallares R, Alonso T et al. Trends in antimicrobial resistance of clinical isolates of Streptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain (1979-1990). Clin Infect Dis 1992; 15: 99-105.
22. de la Campa AG, Ardanuy C, Balsalobre L et al. Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain. Emerg Infect Dis 2009; 15: 905-11.
23. Fuller JD, Low DE. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance. Clin Infect Dis 2005; 41: 118-21.
24. Brueggemann AB, Peto TE, Crook DW et al. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 2004; 190: 1203-11.
25. Alanee SR, McGee L, Jackson D et al. Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study. Clin Infect Dis 2007; 45: 46-51.
26. Sjostrom K, Spindler C, Ortqvist A et al. Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis 2006; 42: 451-9.
27. Arbique JC, Poyart C, Trieu-Cuot P et al. Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. J Clin Microbiol 2004; 42: 4686-96.
28. Simoes AS, Sa-Leao R, Eleveld MJ et al. Highly penicillin-resistant multidrug-resistant pneumococcus-like strains colonizing children in Oeiras, Portugal: genomic characteristics and implications for surveillance. J Clin Microbiol 2010; 48: 238-46.
29. Schenkein JG, Nahm MH, Dransfield MT. Pneumococcal vaccination for patients with COPD: current practice and future directions. Chest 2008; 133: 767-74.
30. Dransfield MT, Nahm MH, Han MK et al. Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180: 499-505.